International Journal of Cytokine Research
Publishing breakthrough research in cytokine signaling, immune regulation, inflammatory responses, therapeutic modulation, and biomarker discovery advancing our understanding of immune communication networks and improving patient outcomes through evidence-based immunotherapy worldwide.
Join a global community of immunologists, rheumatologists, pharmaceutical scientists, and clinical researchers pioneering cytokine-targeted therapies transforming treatment of autoimmune diseases, cancer, and inflammatory conditions.
Why Researchers Trust Us
Fast Publication
Average 4 weeks to first decision, 3 weeks to publication after acceptance
Expert Review
35+ editorial board members specializing in cytokine biology and immunology
Global Reach
Research disseminated to immunology professionals in 45+ countries immediately
Rigorous Standards
Double-blind peer review ensuring highest scientific quality and reproducibility
Bridging Discovery and Clinical Application
The International Journal of Cytokine Research serves as the premier platform for disseminating cutting-edge research advancing our understanding of immune signaling from molecular mechanisms to clinical therapeutics improving patient outcomes globally through evidence-based cytokine-targeted interventions and biomarker-guided treatment strategies.
We publish comprehensive investigations spanning cytokine receptor signaling through JAK-STAT TOR and MAPK pathways, inflammatory cytokine regulation including TNF IL-1 and IL-6 production and secretion, anti-inflammatory cytokine mechanisms modulating immune responses, therapeutic antibodies blocking cytokine activity, cytokine biomarkers predicting disease activity and treatment response, and clinical trials evaluating efficacy and safety of cytokine-targeted biologics transforming treatment of rheumatoid arthritis inflammatory bowel disease psoriasis and other immune-mediated inflammatory diseases benefiting millions of patients worldwide.
Research Focus Areas
Cytokine Signaling
Receptor binding, JAK-STAT pathway activation, downstream gene transcription, feedback regulation mechanisms, cross-talk between pathways, and signaling pathway dysregulation in disease states requiring therapeutic intervention.
Inflammatory Regulation
Pro-inflammatory cytokine production including TNF-alpha IL-1 IL-6 driving tissue damage, anti-inflammatory cytokine balance through IL-10 TGF-beta, resolution phase mediators, and chronic inflammation pathophysiology.
Therapeutic Modulation
Monoclonal antibodies blocking TNF IL-6 IL-17 improving autoimmune disease outcomes, JAK inhibitors preventing signaling, cytokine traps neutralizing ligands, and combination immunotherapy strategies.
Cytokine Storm
Hyperinflammatory syndrome pathophysiology, severe infection complications, hemophagocytic lymphohistiocytosis, CAR-T therapy toxicity, therapeutic interventions including IL-6 and IL-1 blockade.
Cancer Immunotherapy
IL-2 enhancing T cell proliferation, interferon-gamma antitumor effects, IL-12 NK cell activation, checkpoint inhibitor combination strategies, cytokine release syndrome management.
Biomarker Discovery
Cytokine profiling predicting disease activity, treatment response biomarkers guiding therapy selection, minimal residual disease monitoring, personalized medicine approaches.
Membership Investment
Select the tier supporting your cytokine research dissemination goals
Membership Questions?
Contact our editorial team for assistance with membership and publication inquiries.
[email protected]Publish Your Cytokine Research
Submit your immunology and cytokine research for expert peer review and immediate global open access distribution advancing immune science worldwide.